E. Plotnikov, Maria S Tretayakova, Konstantin S. Brazovskii, M. Belousov, A. Artamonov, S. Stuchebrov, A. Gogolev, M. Larkina, E. Sukhikh
{"title":"Radiosensitizing Effects of Lithium Ascorbate on Normal and Tumor\nLymphoid Cells under X-ray Irradiation","authors":"E. Plotnikov, Maria S Tretayakova, Konstantin S. Brazovskii, M. Belousov, A. Artamonov, S. Stuchebrov, A. Gogolev, M. Larkina, E. Sukhikh","doi":"10.2174/1573407219666230503094421","DOIUrl":null,"url":null,"abstract":"\n\nThe study aimed to assess the radiosensitizing effect of lithium ascorbate on tumor cells.\n\n\n\nCancer cells radioresistance is an important factor restraining the success of X-ray\ntherapy. Radiosensitizing drugs make tumor cells more sensitive to ionizing radiation and improve\nthe effectiveness of radiotherapy. Although many chemical substances can potentiate the cytotoxic\neffects of X-ray radiation, their clinical applications are limited due to possible adverse reactions.\nRecently, several approaches have been proposed to develop new radiosensitizers that are highly\neffective and feature low toxicity. Among new enhancers of X-ray therapy, ascorbic acid, and its\nderivates demonstrate very low toxicity along with a wide therapeutic range. Lithium ascorbate is a\npromising X-ray therapy enhancer, but its mechanism of action is unknown. This research focuses\non the radiosensitizing properties of lithium ascorbate and its effects on both tumor and normal irradiated\ncells.\n\n\n\nThe viability of the radiosensitized cells was evaluated by fluorescence flow cytometry\nusing Annexin V-FITC Apoptosis Detection Kit and Cellular ROS Assay Kit (Abcam, UK). The\ntest cell cultures included normal human mononuclear and Jurkat cells.\n\n\n\nLithium ascorbate sensitizes normal human mononuclear and Jurkat cells towards ionizing\nradiation. The combined cytotoxic effect of X-ray irradiation (3 Gy) and lithium ascorbate (1,2\nmmol/L) substantially exceeds the effects of the individual factors, i.e. synergetic action appears.\nThe major types of cell death were late apoptosis and necrosis caused by excessive production of\nreactive oxygen species.\n\n\n\nLithium ascorbate in combination with X-ray irradiation exhibited the cytotoxic effect\non both normal and cancer lymphoid cells by activating reactive oxygen species (ROS)-induced\napoptosis. These findings indicate that lithium ascorbate is a promising substance to develop a new\nradiosensitizing drug.\n","PeriodicalId":10772,"journal":{"name":"Current Bioactive Compounds","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioactive Compounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573407219666230503094421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 1
Abstract
The study aimed to assess the radiosensitizing effect of lithium ascorbate on tumor cells.
Cancer cells radioresistance is an important factor restraining the success of X-ray
therapy. Radiosensitizing drugs make tumor cells more sensitive to ionizing radiation and improve
the effectiveness of radiotherapy. Although many chemical substances can potentiate the cytotoxic
effects of X-ray radiation, their clinical applications are limited due to possible adverse reactions.
Recently, several approaches have been proposed to develop new radiosensitizers that are highly
effective and feature low toxicity. Among new enhancers of X-ray therapy, ascorbic acid, and its
derivates demonstrate very low toxicity along with a wide therapeutic range. Lithium ascorbate is a
promising X-ray therapy enhancer, but its mechanism of action is unknown. This research focuses
on the radiosensitizing properties of lithium ascorbate and its effects on both tumor and normal irradiated
cells.
The viability of the radiosensitized cells was evaluated by fluorescence flow cytometry
using Annexin V-FITC Apoptosis Detection Kit and Cellular ROS Assay Kit (Abcam, UK). The
test cell cultures included normal human mononuclear and Jurkat cells.
Lithium ascorbate sensitizes normal human mononuclear and Jurkat cells towards ionizing
radiation. The combined cytotoxic effect of X-ray irradiation (3 Gy) and lithium ascorbate (1,2
mmol/L) substantially exceeds the effects of the individual factors, i.e. synergetic action appears.
The major types of cell death were late apoptosis and necrosis caused by excessive production of
reactive oxygen species.
Lithium ascorbate in combination with X-ray irradiation exhibited the cytotoxic effect
on both normal and cancer lymphoid cells by activating reactive oxygen species (ROS)-induced
apoptosis. These findings indicate that lithium ascorbate is a promising substance to develop a new
radiosensitizing drug.
Current Bioactive CompoundsPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.90
自引率
0.00%
发文量
112
期刊介绍:
The journal aims to provide comprehensive review articles on new bioactive compounds with proven activities in various biological screenings and pharmacological models with a special emphasis on stereoeselective synthesis. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia. The journal should prove to be essential reading for pharmacologists, natural product chemists and medicinal chemists who wish to be kept informed and up-to-date with the most important developments on new bioactive compounds of natural or synthetic origin, including their stereoeselective synthesis.